To predict the prognosis of glioma patients, we constructed a nomogram that integrated IER5 expression and independent clinical risk factors (WHO grade, IDH status, primary therapy outcome, age, and 1p/19q codeletion; Figure 4D). This evidence concerns the gene IER5 and glioma.